Surgery All of the following are true about CRASH-2 trial except: A Dose of tranexamic acid is 1 gm IV over 10 minutes followed by 1 gm over 8 hours B Given to all trauma patients suspected to have significant hemorrhage including SBP <110 mm Hg or PR >110/min C Should be administered within 3 hours of injury D Tranexamic acid reduces the risk of moality from bleeding in blunt trauma but not in penetrating trauma π‘ Explanation All of the following are true about CRASH-2 trial except: β Correct Answer: D. Tranexamic acid reduces the risk of moality from bleeding in blunt trauma but not in penetrating trauma